| 000 | 01463 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250518073017.0 | ||
| 264 | 0 | _c20210122 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1099-1557 | ||
| 024 | 7 |
_a10.1002/pds.4915 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAkator, Adjo Enyonam | |
| 245 | 0 | 0 |
_aExposure to guideline-recommended drugs after a first acute myocardial infarction in older adults: does deprivation matter? _h[electronic resource] |
| 260 |
_bPharmacoepidemiology and drug safety _c02 2020 |
||
| 300 |
_a141-149 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xeconomics |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAngiotensin Receptor Antagonists _xeconomics |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xeconomics |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aPractice Guidelines as Topic _xstandards |
| 650 | 0 | 4 |
_aQuebec _xepidemiology |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSocioeconomic Factors |
| 700 | 1 | _aBlais, Claudia | |
| 700 | 1 | _aGamache, Philippe | |
| 700 | 1 | _aLunghi, Carlotta | |
| 700 | 1 | _aGuénette, Line | |
| 773 | 0 |
_tPharmacoepidemiology and drug safety _gvol. 29 _gno. 2 _gp. 141-149 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/pds.4915 _zAvailable from publisher's website |
| 999 |
_c30381729 _d30381729 |
||